The most inclusive Real World
Data Platform

Contract Research Organisations

Protocol design

RWE and RWD can be used to inform protocol design, including patient selection criteria, study endpoints, and sample size.

Patient recruitment

RWE and RWD can be used to support patient recruitment efforts by identifying eligible patients and providing insights into patient preferences and behaviors.

Comparative effectiveness research

RWE and RWD can be used to support comparative effectiveness research, which compares the effectiveness of different treatments, interventions, or healthcare strategies in real-world settings.

Post-marketing surveillance

RWE and RWD can be used to monitor the safety and effectiveness of drugs and medical devices in real-world settings after they have been approved and brought to market.

Health economics and outcomes research

RWE and RWD can be used to support health economics and outcomes research, which analyzes the costs and outcomes associated with different healthcare interventions and strategies.

RWE and RWD can be used to support regulatory submissions by providing real-world evidence of the safety and effectiveness of new drugs or medical devices.

Overall, RWE and RWD can help CROs to design more efficient and effective clinical trials, generate new insights and knowledge about disease and treatment, and support the development of new drugs and medical devices.

Insurance Companies

Risk assessment

RWE and RWD can be used to assess risk and predict future health outcomes, which can help insurance companies to price their products appropriately and better manage their risk.

Underwriting

RWE and RWD can be used to support underwriting decisions by providing insights into patient health status, disease prevalence, and treatment patterns.

Claims management

RWE and RWD can be used to support claims management by providing real-world evidence of the effectiveness and value of different treatments and interventions.

Product development

RWE and RWD can be used to inform the development of new insurance products, such as disease-specific policies or policies that incentivize healthy behaviors.

Fraud detection

RWE and RWD can be used to support fraud detection efforts by identifying patterns of fraudulent behavior or potential abuse of insurance products.

Patient engagement:

RWE and RWD can be used to support patient engagement efforts by providing patients with insights into their health status, treatment options, and disease management strategies.

Overall, RWE and RWD can help insurance companies to better understand their patients, manage their risk, and develop products and services that better meet the needs of their customers. 

Healthcare Companies

Clinical trial design and execution

RWE and RWD can be used to inform clinical trial design, including patient selection, study endpoints, and sample size. In addition, RWD can be used to support the recruitment of trial participants and to monitor safety and efficacy during the trial.

Drug development and approval

RWE and RWD can be used to support drug development and approval, including identifying unmet medical needs, understanding disease progression, and assessing the safety and efficacy of new drugs.

Market access and pricing

RWE and RWD can be used to support market access and pricing decisions by providing evidence of a drug's effectiveness and value in real-world settings.

Post-marketing surveillance and safety monitoring

RWE and RWD can be used to monitor the safety and effectiveness of drugs and medical devices in real-world settings, helping to identify potential safety issues and inform regulatory decisions.

Disease surveillance and management

RWE and RWD can be used to track disease incidence and prevalence, identify risk factors, and support disease management and prevention efforts.

Patient engagement and education

RWE and RWD can be used to support patient engagement and education efforts, including understanding patient preferences, improving patient outcomes, and identifying areas for intervention and improvement.

Hospitals & Clinics

Quality improvement

RWE and RWD can be used to support quality improvement efforts by identifying areas for improvement, evaluating the effectiveness of interventions, and monitoring outcomes over time.

Resource allocation

RWE and RWD can be used to inform resource allocation decisions by identifying patient populations that may benefit most from specific interventions or treatments.

Patient safety

RWE and RWD can be used to identify potential safety issues and support patient safety initiatives, such as reducing hospital-acquired infections, minimizing medication errors, and improving patient outcomes.

Population health management

RWE and RWD can be used to support population health management efforts by identifying high-risk patient populations, tracking disease incidence and prevalence, and monitoring outcomes.

Clinical decision-making

RWE and RWD can be used to support clinical decision-making by providing clinicians with real-world evidence of the effectiveness of different treatments, medications, and interventions.

Research and innovation

RWE and RWD can be used to support research and innovation by providing access to large datasets that can be used to generate new insights and knowledge about disease, treatment, and outcomes.

Government Organizations

Health policy development

RWE and RWD can be used to inform health policy development by providing insights into disease prevalence, treatment patterns, and healthcare utilization.

Public health surveillance

RWE and RWD can be used to support public health surveillance efforts by tracking disease incidence and prevalence, identifying outbreaks, and monitoring health outcomes over time.

Resource allocation

RWE and RWD can be used to inform resource allocation decisions by identifying patient populations that may benefit most from specific interventions or treatments.

Comparative effectiveness research

RWE and RWD can be used to support comparative effectiveness research, which compares the effectiveness of different treatments, interventions, or healthcare strategies in real-world settings.

Post-marketing surveillance

RWE and RWD can be used to monitor the safety and effectiveness of drugs and medical devices in real-world settings after they have been approved and brought to market.

Regulatory decision-making

RWE and RWD can be used to support regulatory decision-making by providing real-world evidence of the safety and effectiveness of new drugs or medical devices.

Regulatory Authorities

Regulatory decision-making

RWE and RWD can be used to support regulatory decision-making by providing real-world evidence of the safety and effectiveness of new drugs or medical devices.

Post-marketing surveillance

RWE and RWD can be used to monitor the safety and effectiveness of drugs and medical devices in real-world settings after they have been approved and brought to market.

Comparative effectiveness research

RWE and RWD can be used to support comparative effectiveness research, which compares the effectiveness of different treatments, interventions, or healthcare strategies in real-world settings.

Labeling decisions

RWE and RWD can be used to support labeling decisions by providing insights into the real-world use and effectiveness of drugs and medical devices.

Risk assessment

RWE and RWD can be used to assess the risks associated with drugs and medical devices in real-world settings.

Real-world benefit-risk assessment

RWE and RWD can be used to support real-world benefit-risk assessment of drugs and medical devices by providing insights into the real-world benefits and risks associated with their use.

Laboratories

Improved research

RWE and RWD can be used to support laboratory research by providing real-world insights into the effectiveness and safety of new therapies or interventions.

Data collection

Laboratories can use RWD to collect data from different sources, such as electronic health records or patient registries, to inform their research and analysis.

Clinical trial design

RWE and RWD can be used to inform the design of clinical trials by providing insights into patient populations, disease progression, and treatment outcomes in real-world settings.

Precision medicine

RWE and RWD can support precision medicine by providing insights into patient populations that are most likely to respond to specific treatments or interventions.

Diagnostic testing

RWE and RWD can be used to improve diagnostic testing by providing insights into the real-world performance of different tests and how they are used in clinical practice.

Quality improvement

RWE and RWD can be used to support quality improvement efforts by identifying areas where healthcare providers can improve patient outcomes or reduce costs.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest product or an exclusive offer.